Randy Milby - 01 Jan 2023 Form 4/A - Amendment Insider Report for Hillstream BioPharma Inc. (THAR)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Randy Milby
Issuer symbol: THAR
Transactions as of: 01 Jan 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 13 Mar 2023, 16:17:27 UTC
Date Of Original Report: 04 Jan 2023
Previous filing: 21 Jun 2022
Next filing: 04 Dec 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HILS	Options (right to purchase)	Award	$0	+515,127		$0.000000	515,127	01 Jan 2023	Common stock	515,127	$0.3900	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were issued pursuant to the Issuer's 2019 Stock Incentive Plan and vested in full upon grant.

Remarks:

This Form 4 is filed to amend the Form 4 filed by the Reporting Person on January 4, 2023 (the "Original Form 4"). The Original Form 4 is hereby amended to reflect that the Reporting Person should have received options to purchase 515,127 shares of the Issuer's common stock as there were only 515,127 shares of the Issuer's common stock available for issuance under the Issuer's 2019 Stock Incentive Plan on the date of grant.